Litcius/Paper detail

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma

Yonghyun Choi, Wooic Son, Youngpin Han, Jayoung Chae, Chul‐Su Yang, Jonghoon Choi

2022Acta Pharmaceutica Sinica B26 citationsDOIOpen Access PDF

Abstract

Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed “don't eat me” signals; these signals include sialic acid-binding immunoglobulin-type lectin-10 (Siglec-10) and the recently revealed CD24 immune checkpoint (ICP). In this study, we demonstrate that targeting a specific glycan on CD24 exhibits the potential to inhibit ICP. Sambucus nigra agglutinin (SNA), a sialic acid-binding lectin, was employed to block CD24 and to enhance phagocytosis in melanoma tumours. In addition, we prepared SNA-conjugated hollow gold-iron oxide nanoparticles for photothermal therapy of tumours. Our findings show that the combination treatment of SNA-conjugated photothermal nanoparticles and near-infrared exposure successfully augments tumour cell phagocytosis both in vitro and in vivo models.

Topics & Concepts

GlycanPhagocytosisPhotothermal therapyChemistrySIGLECLectinImmune systemAgglutininIn vitroIn vivoSialic acidMelanomaCancer researchBiochemistryCell biologyImmunologyGlycoproteinBiologyNanotechnologyMaterials scienceBiotechnologyImmunotherapy and Immune ResponsesNanoplatforms for cancer theranosticsCancer Immunotherapy and Biomarkers